CHAVEZ R. MARTIN — SEC insider filings
SEC reporting owner CIK 1157983. 32 insider filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2021-04-19 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 64.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alphabet Inc. (GOOGL) | Director | 16 | — | — | 40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 16 | — | — | 24 |
Insider filings — CHAVEZ R. MARTIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 0.40 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 | EDGAR |
| 2026-09-03 | 4 | Alphabet Inc. (GOOGL) | Gift (G): 1,181 @ $0 | EDGAR |
| 2026-07-06 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 980 @ $0 | EDGAR |
| 2026-06-17 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 0.20 @ $0 · Grant/award (A): 0.50 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 | EDGAR |
| 2026-03-18 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 | EDGAR |
| 2025-12-17 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 1 @ $0 · Grant/award (A): 0.80 @ $0 · Grant/award (A): 0.90 @ $0 · Grant/award (A): 1 @ $0 | EDGAR |
| 2025-09-17 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 2 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 1 @ $0 · Grant/award (A): 2 @ $0 | EDGAR |
| 2025-07-11 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 2,016 @ $0 | EDGAR |
| 2025-06-18 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 3 @ $0 · Grant/award (A): 2 @ $0 · Grant/award (A): 2 @ $0 | EDGAR |
| 2025-03-18 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 4 @ $0 · Grant/award (A): 2 @ $0 · Grant/award (A): 2 @ $0 | EDGAR |
| 2024-12-17 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 4 @ $0 · Grant/award (A): 2 @ $0 · Grant/award (A): 2 @ $0 | EDGAR |
| 2024-09-18 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 5 @ $0 · Grant/award (A): 3 @ $0 · Grant/award (A): 2 @ $0 | EDGAR |
| 2024-07-05 | 4 | Alphabet Inc. (GOOGL) | Grant/award (A): 1,953 @ $0 | EDGAR |
| 2024-06-18 | 4 | Alphabet Inc. (GOOG) | Grant/award (A): 2 @ $0 · Grant/award (A): 5 @ $0 | EDGAR |
| 2024-04-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,001 @ $0 | EDGAR |
| 2024-01-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,900 @ $0 | EDGAR |
| 2023-10-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,619 @ $0 | EDGAR |
| 2023-07-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,541 @ $0 | EDGAR |
| 2023-07-06 | 4 | Alphabet Inc. (GOOG) | Grant/award (A): 2,841 @ $0 | EDGAR |
| 2023-06-21 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 12,612 @ $0 · Grant/award (A): 25,224 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,721 @ $0 | EDGAR |
| 2023-01-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,483 @ $0 | EDGAR |
| 2022-10-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,725 @ $0 | EDGAR |
| 2022-08-09 | 4 | Alphabet Inc. (GOOG) | Grant/award (A): 8,824 @ $0 | EDGAR |
| 2022-07-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,224 @ $0 | EDGAR |
| 2022-06-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 18,145 @ $0 · Grant/award (A): 36,290 (derivative) @ $0 | EDGAR |
| 2022-04-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,438 @ $0 | EDGAR |
| 2022-01-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,040 @ $0 | EDGAR |
| 2021-10-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 858 @ $0 | EDGAR |
| 2021-07-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 521 @ $0 | EDGAR |
| 2021-04-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 6,250 · Conversion (C): 6,250 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1157983 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs